Docoh
Loading...

EVGN Evogene

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
19 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's morning trading, 400 companies set new 52-week lows.
Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms
18 Jan 22
Cannabis, News, Penny Stocks, Markets
Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), revealed Tuesday that it had seen positive results in pre-clinical studies in inflammatory and pain model systems.
Evogene Subsidiary Canonic Announce Results In Pre-Clinical Studies In Inflammatory And Pain Model Systems Conducted By Hadassah Medical Center And Migal - Galilee Research Institute
18 Jan 22
General
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), announced today positive results in pre-clinical studies in
Stocks That Hit 52-Week Lows On Friday
14 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Friday's session, 445 companies made new 52-week lows.
Evogene's Biomica Announces Clearance For First-In-Human Phase I Study Of BMC-128 In Combination With Bristol Myers Squibb's Anti-PD-1 Opdivo
11 Jan 22
Biotech, News, FDA, General
REHOVOT, Israel, Jan. 11, 2022 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:
Stocks That Hit 52-Week Lows On Thursday
6 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Thursday, 615 stocks hit new 52-week lows.
Evogene Subsidiary Lavie Bio Announces Advancement In Its Bio-Fungicide Program For Fruit Rots
14 Dec 21
Analyst Ratings, General
Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd.
Evogene Subsidiary Biomica Reports Results From Pre-Clinical Studies In Inflammatory Bowel Disease Program
30 Nov 21
Biotech, General
REHOVOT, Israel, Nov. 30, 2021 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
19 Nov 21
Cannabis, Earnings, M&A, News, Penny Stocks, Guidance, Health Care, Financing, Small Cap, Exclusives, Markets, Tech, General
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. Contents
Evogene Reports Slight YoY Boost In Q3 Revenue, Looks To Turn Subsidiaries Into Public Companies
17 Nov 21
Cannabis, Earnings, News, Penny Stocks, Markets
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), the parent company of medical cannabis-focused Canonic, reported its financial results Wednesday for the first nine months and third quarter of 2021.
Evogene Q3 EPS $(0.19) Misses $(0.17) Estimate, Sales $151.00K Miss $270.00K Estimate
17 Nov 21
Earnings, News
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 11.76 percent decrease over losses of $(0.17) per share from the
Earnings Scheduled For November 17, 2021
17 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion.
Evogene Subsidiary Lavie Bio Highlights Commercial Launch Of Its First Product, LAV.211, An Inoculant For Yield Improvement, Under The Brand Name 'result'
3 Nov 21
News
Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction

Press releases

From Benzinga Pro
Evogene to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference from January 25-27th, 2022
19 Jan 22
Press Releases
REHOVOT, Israel, Jan. 19, 2022 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), announced today it is participating in Edison Group's Open House Event, scheduled to take place virtually this month. For more
Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis
18 Jan 22
Press Releases
REHOVOT, Israel, Jan. 18, 2022 /PRNewswire/ -- Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), announced today
Biomica Announces Clearance for First-in-Human Phase I Study of BMC-128 in Combination with Bristol Myers Squibb's Anti-PD-1 Opdivo®
11 Jan 22
Press Releases
REHOVOT, Israel, Jan. 11, 2022 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today
Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots
14 Dec 21
Commodities, Press Releases
REHOVOT, Israel, Dec. 14, 2021 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction of
Hiscox EU Pan-European Transformation Goes Live in Germany with Sapiens Solutions in the Cloud
30 Nov 21
Fintech, Insurance, Press Releases
HOLON, Israel, Nov. 30, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the financial services industry, announced today that
Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program
30 Nov 21
Press Releases
REHOVOT, Israel, Nov. 30, 2021 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), reported
Evogene Reports Third Quarter 2021 Financial Results
17 Nov 21
Earnings, Press Releases
REHOVOT, Israel, Nov. 17, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple
Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium
10 Nov 21
Press Releases
REHOVOT, Israel, Nov. 10, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments,
Lavie Bio Announces Commercial Launch of its First Microbiome-Based Product for Yield Improvement - result™
3 Nov 21
Press Releases
REHOVOT, Israel, Nov. 3, 2021 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality and agricultural productivity
Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug
27 Oct 21
News, Contracts, Press Releases
REHOVOT and HAIFA, Israel, Oct. 27, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:
Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021
27 Oct 21
Press Releases
REHOVOT, Israel, Oct. 27, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market